Regional disparity on patient characteristics and perceptions after implantable cardioverter-defibrillator implantation: results from an EHRA patient survey

Abstract Aims The aim of this study was to identify potential regional disparities in characteristics of implantable cardioverter-defibrillator (ICD) recipients, patient perceptions and perspectives after implantation and level of information provided to patients. Methods and results The prospective...

Full description

Saved in:
Bibliographic Details
Published inEuropace (London, England) Vol. 25; no. 5
Main Authors Januszkiewicz, Łukasz, Barra, Sérgio, Providencia, Rui, Chun, Julian K R, Conte, Giulio, Farkowski, Michał M, Guerra, Jose M, Marijon, Eloi, de Asmundis, Carlo, Boveda, Serge
Format Journal Article
LanguageEnglish
Published US Oxford University Press 19.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aims The aim of this study was to identify potential regional disparities in characteristics of implantable cardioverter-defibrillator (ICD) recipients, patient perceptions and perspectives after implantation and level of information provided to patients. Methods and results The prospective, multicentre, and multinational European Heart Rhythm Association patient Survey ‘Living with an ICD’ included patients already implanted with an ICD (median ICD dwell time – 5 years, interquartile range 2–10). An online questionnaire was filled-in by patients invited from 10 European countries. A total of 1809 patients (the majority in their 40s to 70s, 65.5% men) were enrolled, with 877 (48.5%) from Western Europe (group 1), followed by 563 from Central/Eastern Europe (group 2, 31.1%), and 369 from Southern Europe (group 3, 20.4%). A total of 52.9% of Central/Eastern Europe patients reported increased satisfaction after ICD placement compared with 46.6% from Western and 33.1% from Southern Europe (1 vs. 2 P = 0.047, 1 vs. 3 P < 0.001, 2 vs. 3 P < 0.001). About 79.2% of Central/Eastern and 76.0% of Southern Europe patients felt optimally informed at the time of device implantation compared with just 64.6% from Western Europe (1 vs. 2 P < 0.001, 1 vs. 3 P < 0.001, 2 vs. 3 P = ns). Conclusions While physicians in Southern Europe should address the patients’ concerns about the impact of the ICD on quality of life, physicians from Western Europe should focus on improving the quality of information provided to their prospective ICD patients. Novel strategies to address regional differences in patients’ quality of life and provision of information are warranted. Graphical Abstract Graphical Abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conflict of interest: Ł.J. has received speaker/consultant fees from Biotronik, Medtronic. G.C. has received research grants from the Swiss National Foundation and research grants and speaker fees from Boston Scientific. M.M.F. has received speaker/proctoring fees from Abbott Medical Poland and Medtronic Poland. J.M.G. has served as consultant for Boston-Scientific, Abbott and ZOLL, received speaker fees from Boston-Scientific, Microport, Abbott and ZOLL, and received research grants from Medtronic and Abbott. E.M. has served as a consultant for Boston Scientific, Medtronic and Abbott and received research grants from Boston Scientific, Medtronic, Abbott, Biotronik, and Microport. S.B. has served as consultant for Medtronic, Boston Scientific, Microport, and Zoll. All the other authors have no conflict of interest to declare.
ISSN:1099-5129
1532-2092
DOI:10.1093/europace/euad110